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Objectives. To explore whether distinct trajectories of anxiety and depression exist
among liver transplant candidates, and to gain insight into demographic, clinical, and
individual characteristics related with these trajectories.
Design. Amulticentre, prospective cohort study among 216 liver transplant candidates.
Respondents filled out a questionnaire at study entrance and subsequently every
6 months until transplantation or removal from the waiting list.
Methods. Anxiety (STAI6), depression (CES-D), demographic, and individual variables
were assessed by questionnaire. Clinical variables were retrieved by medical record
review. The SAS PROC TRAJ procedure was used to identify distinct trajectories.
Univariate and multiple ordinal logistic regression analyses were used to explore related
variables.
Results. Regarding anxiety, three stable trajectories were identified as follows: below
clinical level (51%), slightly above clinical level (34%), and high above clinical level (15%).
Regarding depression, four stable trajectories were identified as follows: below clinical
level (23%), slightly below clinical level (34%), slightly above clinical level (28%), and high
above clinical level (6%). For anxiety as well as for depression, experiencing more liver
disease symptoms, a lower level of personal control, making more use of emotional
coping, and making less use of task-oriented coping increased the likelihood of
membership in those trajectories with higher symptom levels.
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Conclusion. Distinct, but stable, trajectories of anxiety and depression were present in
liver transplant candidates. The trajectories with symptom levels above clinical relevant
levels for anxiety or depression comprised, respectively, 49% and34%of the respondents.
Therefore, psychological screening and subsequently providing appropriate interventions
are warranted early in the transplant process.
Statement of contribution
What is already known on this subject
 For transplant candidates, the waiting-list period is a period of uncertainty and unpredictability.
 Psychological problems, such as anxiety and depression, are common among liver transplant
candidates.
 Several demographic, clinical, and individual characteristics are associated with anxiety and
depression, but these results remain inconclusive.
What does this study add
 Distinct trajectories of symptoms of anxiety and depression are present among liver transplant
candidates.
 Given the stability of the trajectories over time, the symptom level at baseline is indicative of the
symptom level during the waiting-list period.
 Experiencingmore liver disease symptoms, lowmastery,more useof emotional coping, and less use
of task-oriented coping are associated with trajectories of high symptom levels.
In the Eurotransplant region, over 2,000 patients with end-stage liver disease are waiting
for a liver transplant, while about 1,600 patients per year receive a liver transplant
(Eurotransplant International Foundation, 2015). More specifically, in the Netherlands,
about 200 patients are placed on the waiting list for a liver transplant per year, while
approximately 145 patients receive a liver transplant (Dutch Transplantation Society,
2015). Due to the gap between supply and demand for organ donors, transplant
candidates may have to wait for a donor offer for a prolonged period of time. Each year
approximately 15% of transplant candidates die while on the organ transplant waiting list
(Dutch Transplantation Society, 2015).
Waiting for a new organ puts much stress on patients. Not only are they confronted
with deterioration in their physical health but they also have to dealwith uncertainty –will
the transplant come in time – and unpredictability – when will the transplant take place
(Haugh& Salyer, 2007;Martin, Stone, Scott, &Brashers, 2010;Moran, Scott, &Darbyshire,
2011; Toimamueang et al., 2003). Although the prospect of a transplantation offers new
hope for the future, transplant candidates often feel that their life is on hold (Moran et al.,
2011; Rosenberger, Dew, DiMartini, DeVito Dabbs, & Yusen, 2012).
Given the stressors encountered by transplant candidates, it is not surprising that
psychological problems, such as anxiety anddepression, are commonduring thewaiting-list
period. Among liver transplant candidates, prevalence rates of 14–52% regarding anxiety
(Gutteling, de Man, Busschbach, & Darlington, 2007; Lopez-Navas et al., 2011; Miller et al.,
2013; Russell, Feurer, Wisawatapnimit, Salomon, & Pinson, 2008; Stewart, Hart, Gibson, &
Fisher, 2014) andof 17–60% regardingdepression (Guimaro, Lacerda,Karam, Ferraz-Neto,&
Andreoli, 2008; Gutteling et al., 2007; Lopez-Navas et al., 2011; Miller et al., 2013; Russell
et al., 2008; Stewart et al., 2014) have been described. These prevalence rates vary widely
because of differences in screening instruments and cut-off scores used.
Psychological problems before transplantation have been associated with poor
psychological health after transplantation (Caccamo et al., 2001; Miller et al., 2013;
Rogal, Landsittel, Surman, Chung, & Rutherford, 2011),which in turn has been associated
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with poorer outcomes after transplantation regarding adherence (Chiu, Chen, & Cheng,
2009; Errichiello, Picozzi, & de Notaris, 2014), quality of life (Errichiello et al., 2014;
Kugler et al., 2013; Miller et al., 2013), and mortality (Corruble et al., 2011; Rogal, Dew,
Fontes, & DiMartini, 2013). Therefore, effective treatment of symptoms of anxiety and
depression during the waiting-list period may contribute to an optimal preparation for
transplantation and better outcomes after transplantation.
So far, little is known about the evolution of symptoms of anxiety and depression
during thewaiting-list period, becausemost studies describing prevalence rates of anxiety
and depression have a cross-sectional design, and data are often assessed before or shortly
after placement on thewaiting list. Regarding liver transplant candidates, two studies have
described the course of symptoms of depression and anxiety as remaining stable during
the first 6 months after placement on the waiting list (Goetzmann et al., 2006; Malik
et al., 2014). Three studies among lung, heart, and kidney transplant candidates revealed
an increase in symptomsof anxiety anddepression over time during thewaiting-list period
(Corruble et al., 2010; Vermeulen, Bosma, van der Bij, Koeter, &TenVergert, 2005; Zipfel
et al., 1998). However, these studies examined the course of symptoms of anxiety and
depression on a group level. Distinct trajectories, representing clusters of individual
developmental courses for symptoms of anxiety and depression during the waiting-list
period, have not been examined yet. Thus, we do not know whether transplant
candidates become increasingly anxious over time, orwhether transplant candidateswho
are already depressed remain depressed.
Most studies describing on trajectories of anxiety and depression in other chronic
illness patient groups (Ng, Tan,Mooppil, Newman, &Griva, 2015; Yohannes et al., 2016)
or in cancer patients duringmedical treatment (Henselmans et al., 2010; Lam et al., 2013)
distinguished four distinct patterns: chronic low symptom levels, chronic high symptom
levels, increasing symptom levels, and decreasing symptom levels. In most studies, the
majority of respondents (50–68%) showed chronic low symptoms levels, whereas a
minority (9–24%) showed chronic high symptom levels, and 20–30% showed fluctuating
symptom levels. Based on these results, it might be hypothesized that the majority of the
transplant candidates will show low symptom levels of anxiety and depression over time
and that only a minority will show high symptom levels over time. Besides this, a
significant subset of transplant recipients may show an increase in symptom level over
time due to the deterioration in health status and an increase in feelings of uncertainty.
In addition, insight into the demographic, clinical, and individual characteristics that
distinguish the distinct trajectories of symptoms of anxiety and depression can provide
health care workers with valuable insights for interventions aimed at reducing distress
during the waiting-list period. In the literature, several variables have been related with
higher levels of anxiety and/or depression in transplant candidates. These include
demographic characteristics, such as age, sex, marital status, and employment status
(Corruble et al., 2011; Lopez-Navas et al., 2011; Sainz-Barriga et al., 2005; Santos et al.,
2010); clinical characteristics, such as theModel for End-stage LiverDisease (MELD) score;
time on the waiting list; and perceived health status (Gutteling et al., 2007; Martin-
Rodriguez, Perez-San-Gregorio, Dominguez-Cabello, Fernandez-Jimenez, & Perez Bernal,
2012; Rogal et al., 2011) and individual characteristics, such as coping style, personal
control, social support, and self-efficacy (Dew et al., 1994; Gutteling et al., 2007; Lopez-
Navas et al., 2011). However, other studies have shown contradictory results regarding
these factors (Martins, Sankarankutty, Silva, & Gorayeb, 2006; Ye et al., 2013). Although
these variables are related with higher levels of anxiety and depression measured on a
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group level, we have to rely on these studies to identify possible predictors for distinct
trajectories, because studies on distinct trajectories are lacking.
Therefore, the aim of this study was to explore whether distinct trajectories of anxiety
and depression are present in liver transplant candidates, how these trajectories evolve
over time, and to identify which demographic, clinical, and individual characteristics are
related with these trajectories.
Materials and methods
This study was part of a prospective cohort study on psychological aspects of liver
transplantation among transplant patients of three liver transplant centres in the
Netherlands. All transplant candidates on thewaiting list betweenOctober 2009 andApril
2013 were eligible to participate if they were 18 years or older, and received pre-
transplant care in one of the transplant centres. Exclusion criteria were as follows: not
being able to fill out a questionnaire due to physical, mental, or cognitive functioning, or a
language barrier.
Informed consent was obtained from all the individual participants included in the
study. After written informed consent, respondents received a baseline questionnaire
(T0),which theywere asked to fill outwithin 2 weeks. A reminderwas sent after 2 weeks,
if necessary. The measurement of symptoms of anxiety and depression was repeated
every 6 months (T1–T7) after inclusion in the study until either transplantation, removal
from the waiting list, death during the waiting-list period, or the end of the study in
October 2013.
The institutional review board of the transplant centre that initiated the study
approved the study, and a positive recommendation of local feasibility was obtained from
the other transplant centres (METc2009.190).
Measurements
Outcome variables
The outcome variables of anxiety and depressionwere included in the questionnaire at all
measurement points.
Symptoms of anxiety were measured using the short form of the State-Trait Anxiety
Inventory (STAI-6) (Marteau&Bekker, 1992). The STAI-6 consists of six items rated on a 4-
point intensity scale (from 1 = not at all to 4 = very much), resulting in a total sum score
between 6 and 24. Higher scores indicate more symptoms of anxiety. Based on a
transformation of the original 20-item scale cut-off of ≥40 for the general population
(Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983), a cut-off score of ≥12 was used to
identify clinically relevant cases. The convergent validity of the STAI-6, with the full form
of the STAI, showed a correlation of .95 (Van der Bij, De Weerd, Cikot, Steegers, &
Braspenning, 2003). Cronbach’s a of the STAI-6 in this study varied from .75 to .88 at the
different measurement points.
Symptoms of depression were assessed using the Dutch version of the Center for
Epidemiological Studies Depression scale (CES-D) (Bouma, Ranchor, Sanderman, & Van
Sonderen, 1995). The CES-D consists of 20 items, scored on a 4-point self-report scale
(from 0 = seldom or never to 4 = most of the time/always). Higher scores indicate more
symptoms of depression. A cut-off score of ≥16 was used to identify clinically relevant
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cases (Radloff, 1977). Cronbach’s a of the CES-D in this study varied from .79 to .94 at the
different measurement points.
Predictor variables
All predictor variables were measured once at the baseline measurement (T0).
Demographic characteristics regarding age, sex, marital status, educational level, and
employment status were retrieved by self-report.
Clinical characteristics regarding primary liver disease, presence of hepatocellular
carcinoma (HCC), time since diagnosis, time onwaiting list, MELD score at time of listing,
number of comorbidities, and the severity of liver disease symptomswere examined.Most
of the variables were retrieved by medical record review. To measure comorbidity and
liver disease symptoms, two research instruments were included in the questionnaire:
1. Tomeasure comorbidities, a checklist of twenty commonmedical problems adapted
from the health survey of the Dutch central statistics office, Statistics Netherlands,
was used (www.cbs.nl; accessed 01/15/2015). This checklist included common
medical conditions such as pulmonary diseases, heart diseases, stroke, gastrointesti-
nal disorders, kidney function disorder, diabetes mellitus, joint complaints, and
cancer. Respondents were asked to indicatewhichmedical conditions, in addition to
the liver disease, they had (yes/no), and whether they had received treatment (yes/
no) for any of these medical conditions in the past 12 months. The total number of
comorbidities was calculated by adding up all medical conditions for which
treatment was received in the past year. Previous studies suggest that this method of
self-reported comorbidity tends to be an accurate representation of actual comor-
bidity (Kriegsman, Penninx, van Eijk, Boeke, & Deeg, 1996; Van den Bos, 1995).
Moreover, it has been found to be applicable in a transplant population (Schulz et al.,
2013).
2. The Liver Disease Symptom Index 2.0 (LDSI) (Van der Plas et al., 2004) was used to
measure the severity of specific liver disease symptoms. The LDSI includes 18 items,
of which nine measure the severity of liver disease-related symptoms, such as itch,
jaundice, and sleepiness during the day. The other nine itemsmeasure the hindrance
caused by these symptoms in terms of daily activities. All items are scored on a 5-point
Likert scale ranging from ‘not at all’ (0) to ‘to a great extent’ (4). The LSDI has shown
good feasibility and good test–retest reliability (Van der Plas et al., 2004). Two items,
regarding depressive and anxious feelings, were removed from the analyses to avoid
overlap with the outcome variables. In this study, only the severity scale of the LDSI
was used. This scorewas calculatedby summing up the scores of the remaining items.
Regarding individual characteristics, the level of personal control and coping style
used were taken into account, because these are modifiable factors. In addition to these
characteristics, the number of life events was examined as a potential confounder
variable.
1. Personal control, the general perception of control over life, wasmeasured using the
Pearlin-Schooler Mastery Scale (Pearlin & Schooler, 1978). The Mastery Scale
measures the degree to which individuals feel they can control things that happen to
them, and it consists of seven items rated on a 5-point Likert scale (1 = totally
disagree, 5 = totally agree). Total scores range from 7 (low personal control) to 35
(high personal control). The Mastery Scale is used in a variety of well and ill
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populations and has shown good reliability and validity (Pearlin & Schooler, 1978).
Cronbach’s a in this study was .80.
2. Coping stylewasmeasured using the short form of the Coping Inventory for Stressful
Situations (CISS-SF). The CISS-SF measures three dimensions of responses to stressful
circumstances: task-oriented, emotional, and avoidance coping. The CISS-SF consists
of 21 items, where respondents can rate the extent to which they engage in various
types of coping activities, when confronted with stressful situations, on a 5-point
Likert scale (from 1 = not at all to 5 = very much) (Cohan, Jang, & Stein, 2006).
Higher scores on a subscale indicate more use of the specific coping style. In this
study, the Cronbach’s a of the subscales were as follows: .79 for the task-oriented
coping scale, .82 for the emotional coping scale, and .78 for the avoidance coping
scale.
3. Other Stressful life events, in addition to having end-stage liver disease, which may
influence a person’s life and psychological functioning, were measured using the
Trauma and Life Event Self-report Inventory (TLESI) (Hovens, Bramsen, van der Ploeg,
& Reuling, 2000). The TLESI consists of a list of eleven stressful events, where a
person can indicatewhich events happened in the past 5 years. Additional life events
that had an influence on a person’s life could be added. In the analyses, the number of
reported life events was taken into account.
Data analyses
Distinct trajectories were identified using PROC TRAJ in SAS 9.4 (SAS Institute Inc., Cary,
NC, USA), a group-basedmodelling strategy for analysing developmental trajectories over
age or time. PROC TRAJ identifies latent clusters of individuals following a similar course
of development and is able to identify time trajectories of maximally third-order
polynomials in a population. Respondents are assigned to one of the identified trajectories
by calculating the probability of membership in each latent cluster for each respondent
using a censored normal mixture model (Jones, Nagin, & Roeder, 2001). This means that
the response variables (anxiety and depression) are normally distributed within each
trajectory.
To select the best model, several criteria were used as follows: (1) The Bayesian
information criterion (BIC) and the Akaike information criterion (AIC) were used to
measure the relative fit of the model, with lower values indicating a better fit; (2) the
posterior probabilities of group membership, the estimated probability of group
membership for individuals assigned to each group, should exceed a minimum threshold
of 0.7; and (3) an extra class of substantial size (>5%) should be conceptually meaningful
and represent a trajectory differing from trajectories with fewer classes (Nagin & Odgers,
2010).
The waiting-list cohort was a dynamic cohort; subjects were being continuously
enrolled in or removed from the waiting-list group (in case of transplantation, removal
from the waiting list, or death) during the follow-up period. Therefore, the number of
observations for each transplant candidate and the sample sizes per measurement
point varied between one and eight measurements. However, PROC TRAJ can handle
missing data of the type Missing at Random (MAR) and Missing Not at Random
(MNAR) using maximum-likelihood estimation. To check the robustness of our
findings, sensitivity analyses were performed using data from five of the eight
measurements points (T0–T4).
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Cluster membership with respect to the trajectories of anxiety and depression,
identified for each transplant candidate, was added to an IBM SPSS Statistics 22.0 database
(SPSS Inc., Chicago, 2013), which was used for all other analyses. Descriptive statistics
were used to calculate the mean scores or prevalence rates of the demographic, clinical,
and individual characteristics. Univariate ordinal logistic regression (OLR) analysis was
used to examinewhether these characteristics were significantly related with the distinct
trajectories. Characteristics that were significantly related with trajectories were entered
into amultiple OLR analysis to examine the independent effect of these characteristics on
the distinct trajectories using odds ratios.
To test the stability of the trajectories over time, the effect size of partial eta squared
(g2p) was used. Partial eta squared describes the proportion of the total variability
attributable to a factor (Levine & Hullett, 2002). GLM repeated-measures ANOVA with
time as a factor was used to calculate g2p. Because of the small sample sizes in the
measurement points T5–T7, these analyses were performed using the data of the
measurement points T0–T4. p-value was set at .05, two-tailed, for all analyses.
Results
Of the 474 liver transplant candidates on thewaiting list betweenOctober 2009 and April
2013, 350were eligible toparticipate in the study (Figure 1).Of these, 241 liver transplant
candidates (68.9%) agreed to participate. Liver transplant candidates not willing to
participate were significantly younger (48.0 years, 13.6; p = .02) than those willing to
participate. Besides this, candidates with the primary diagnosis of biliary cirrhosis were
more willing to participate (76%, p = .048), whereas candidates within the group of
miscellaneous diseaseswere lesswilling to participate (54%,p = .03). Regarding sex, time
since diagnosis, time onwaiting list, andMELD score, no differenceswere found between
participants and non-participants.
Two hundred and sixteen liver transplant candidates (93.1%) responded to the
baseline questionnaire (T0); 25 did not return the baseline questionnaire for several
reasons (Figure 1).
During the study period, 116 of the respondents received a transplant (53.7%), 15
respondents (6.9%) were removed from the waiting list, and 14 respondents (6.5%) died
during thewaiting-list period (Figure 1). At the end of the study, 71 respondents were still
on the waiting list.
Demographic, clinical, and individual characteristics of the study population are
presented in Table 1.
Trajectories of anxiety during the waiting-list period
Theparameter estimates of the trajectory analysis showed that themodel identifying three
distinct trajectories was the best model for symptoms of anxiety (Table 2). In this model,
the BIC score was the lowest, posterior probabilities exceeded the threshold of >0.7, and
all trajectories comprised >5% of the study population. In Figure 2, the distinct
trajectories of anxiety are depicted, in which the dotted line represents the predicted
values of the cluster-specific trajectories, and the solid line, the observed average values.
The three distinctive trajectories of anxiety were characterized by the following: (1) a
groupwith average symptom scores below the clinical level, comprising 51.3% (n = 118)
of the respondents; (2) a group with average symptom scores slightly above the clinical
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Patients on liver transplant waiting list 




Not invited to participate N = 124 (26.1%)
N = 56 excluded (11.8%) not able to fill out a questionnaire  
- n = 28 due to language
- n = 6 physical functioning
- n = 17 cognitive functioning
- n = 5 mental functioning
N = 68 other reasons (14.3%)
- n = 53 transplantation within one week after enlisting
- n = 10 deceased
- n = 4 retransplantation during study period





No T0 measurement n = 25 
- n = 18 transplantation before questionnaire was filled out
- n = 6 withdrawal informed consent
- n = 1 deceased
T1 (6 months after T0)
n = 122
T2 (12 months after T0)
n = 69
T3 (18 months after T0)
n = 47
T4 (24 months after T0)
n = 26
T5 (30 months after T0)
n = 14
T6 (36 months after T0)
n = 7
T7 (42 months after T0)
n = 6
- n = 72 transplanted
- n = 6 removed from waiting list
- n = 10 deceased
- n = 6 end of study after T0
- n = 28 transplanted 
- n = 7 removed from waiting list
- n = 2 deceased
- n = 16 end of study after T1
- n = 12 transplanted 
- n = 10 end of study after T2
- n = 2 removed from waiting list
- n = 19 end of study after T3
- n = 1 transplanted 
- n = 1 deceased
- n = 10 end of study after T4
- n = 2 transplanted 
- n = 5 end of study after T5
- n = 1 transplanted 
Figure 1. Study inclusion flow diagram.
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level, comprising 33.5% (n = 67) of the respondents; and (3) a group with average
symptom scores high above clinical level, comprising 15.2% (n = 31) of the respondents.
Sensitivity analyses using data of T0–T4 revealed three similar distinctive trajectories (BIC:
2 clusters: 1292.91; 3 clusters: 1288.92; 4 clusters: 1295.37), with an overlap in group
membership in 94.4% of the cases. Regarding the stability of the trajectories over time, the
effect sizes (g2p) were, respectively, .08 for trajectory 1, .15 for trajectory 2, and .20 for
trajectory 3. This indicates that time accounted for 8–20% of the variability in anxiety
scores within the trajectories.
Variables related with the trajectories of anxiety
As shown in Table 3, univariate ordinal logistic regression analyses revealed that the
distinctive trajectories were independently related with the variables: educational level,
the LDSI score, personal control, emotional coping, task-oriented coping, and the number
of life events. Investigating the effects of these variables simultaneously on trajectory





Gender: male 144 (66.7)





Employment status: paid job 64 (29.6)
Nationality: Dutch 200 (92.6)
Primary disease
Biliary cirrhosis 78 (36.1)
Alcoholic cirrhosis 51 (23.6)
Metabolic disorder 24 (11.1)
Viral hepatitis 28 (13.0)
Cirrhosis of unknown origin 18 (8.3)
Miscellaneous 17 (7.8)
Hepato Cellular carcinoma 34 (15.7)
Mean (SD)
Age (in years) 51.6 (11.3)
Number of comorbidities 1.9 (1.6)
Time since diagnosis (in years) 5.8 (6.3)
Time on waiting list (in months) 7.8 (13.9)
MELD score 13.3 (5.3)
LDSI score 9.5 (5.4)
Personal control 23.9 (5.4)
Coping style
Emotional coping 19.2 (6.5)
Task-oriented coping 25.1 (4.3)
Avoidance coping 17.1 (5.0)
Number of life events 1.6 (1.3)
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membership, using multiple ordinal logistic regression analysis, showed that educational
level and the number of life events do not seem to help classify subjects when LDSI,
personal control, emotional coping, and task-oriented coping are already provided
Table 2. Parameters used for model selection regarding trajectories of symptoms of anxiety and
depression
Model BIC AIC Posterior probabilities
%
1 2 3 4 5
Symptoms of anxiety
2 1355.64 1338.77 0.89–0.93 62.6 37.4 – – –
3 1349.24 1323.93 0.77–0.87 51.3 33.5 15.2 – –
4 1354.92 1321.16 0.69–0.86 49.1 6.8 29.2 14.9 –
Symptoms of depression
2 1860.24 1843.36 0.89–0.94 71.1 28.9 – – –
3 1835.48 1810.17 0.84–0.91 75.5 35.0 7.6 – –
4 1824.75 1791.00 0.77–0.92 22.7 43.9 27.7 5.7 –
5 1833.85 1791.66 0.64–0.91 21.0 35.9 12.0 26.0 5.1














Group percents 51.3 33.5 15.2
Figure 2. Distinct trajectories of symptoms of anxiety of liver transplant candidates during the waiting
list period.Note. The bold black line represents the cut-off value (≥12) of the clinical level of symptoms of
anxiety. T0 = baseline measurement, T1 = 6 months after T0, T2 = 12 months after T0,
T3 = 18 months after T0, T4 = 24 months after, T5 = 30 months after T0, T6 = 36 months after
T0, T7 = 42 months after T0. [Colour figure can be viewed at wileyonlinelibrary.com]
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(Table 4). The results of the OLR analysis showed that a unit increase in LDSI score
(OR = 1.16, CI 1.09–1.23) and a unit increase in emotional coping score (OR = 1.13, CI
1.07–1.19)were relatedwith an increase in theoddsofmembership in the trajectorieswith
higher levels of anxiety, while a unit increase in personal control score (OR = 0.89, CI
0.84–0.95) and a unit increase in the task-oriented coping score (OR = 0.89, CI 0.82–0.96)
reduced the odds ofmembership in trajectorieswith higher levels of symptoms of anxiety.
Trajectories of depression during the waiting-list period
Regarding depressive symptoms, themodel with four distinct trajectorieswas found to be
the best model, with the lowest BIC score, posterior probabilities >0.7, and the smallest













n = 31 p-Value
n/%
Gender: Male 78 (66.1) 46 (68.7) 20 (64.5) .94
Marital status: Partner 91 (77.1) 53 (79.1) 24 (77.4) .85
Educational level
Low 23 (19.5) 11 (16.4) 13 (41.9) .30
Moderate 57 (48.3) 31 (46.3) 8 (25.8) .04
High 38 (32.2) 25 (37.3) 10 (32.3) Ref.
Currently employed: Paid job 38 (32.2) 22 (32.8) 4 (12.9) .17
Primary disease
Biliary cirrhosis 45 (38.1) 25 (37.3) 8 (25.8) .48
Alcoholic cirrhosis 29 (24.6) 16 (23.9) 6 (19.4) .63
Metabolic disorder 11 (9.3) 8 (11.9) 5 (16.1) .48
Viral hepatitis 14 (11.9) 6 (9.0) 8 (25.8) .21
Cirrhosis of unknown origin 8 (6.8) 6 (9.0) 4 (12.9) .29
Miscellaneous 11 (9.3) 6 (9.0) – .25
Hepato Cellular Carcinoma 21 (17.8) 10 (14.5) 3 (9.7) .30
Mean (SD)
Age 51.9 (11.3) 51.1 (11.7) 51.8 (11.0) .79
Number of comorbidities 1.7 (1.4) 2.2 (1.9) 2.2 (1.5) .06
Time since diagnosis (in years) 6.4 (7.0) 5.0 (4.8) 5.2 (5.8) .12
Time on waiting list (in months) 6.9 (13.1) 7.9 (15.0) 9.5 (14.6) .36
MELD score 13.3 (5.5) 12.9 (5.4) 14.5 (4.5) .59
LDSI score 7.7 (4.9) 10.5 (4.3) 14.0 (5.7) <.001
Personal control 26.1 (4.8) 22.3 (5.0) 19.1 (4.4) <.001
Coping style
Emotional coping 16.8 (5.4) 21.3 (6.8) 23.5 (5.9) <.001
Task-oriented coping 25.9 (4.2) 25.0 (4.0) 22.6 (4.3) <.001
Avoidance coping 16.6 (5.4) 17.6 (4.7) 17.4 (3.8) .22
Number of life events 1.4 (1.1) 1.7 (1.4) 2.1 (1.5) .01
Note. MELD = Model for End-stage Liver Disease; LDSI = Liver disease Symptom Index; ref.
= reference category.
Bold values are significant.
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group still comprised >5% of the study population (Table 2). In Figure 3, the trajectory
analyses of symptoms of depression are depicted. The four distinctive trajectories of
depression identified can be characterized as follows: (1) a group with average symptom
scores for depression below the clinical level, comprising 22.7% (n = 36) of the
respondents; (2) a group with average symptom scores for depression slightly below
clinical level, comprising 43.9% (n = 104) of the respondents; (3) a group with average
symptom scores for depression slightly above clinical level, comprising 27.7% (n = 66) of
the respondents; and (4) a groupwith average symptom scores for depression high above
the clinical level, comprising 5.7% (n = 10) of the respondents. Sensitivity analyses, using
data from T0–T4, revealed four similar distinctive trajectories (three clusters: 1746.55;
four clusters: 1740.71; five clusters: 1750.09), with an overlap in group membership in
89.4% of the cases. Regarding the stability of the trajectories over time, the effect sizes
(gp
2
)were, respectively, .07 for trajectory 1, .04 for trajectory 2, .03 for trajectory 3, and
.20 for trajectory 4. This indicates that time accounted for 3% to 20% of the variability in
depression scores within the trajectories.
Variables related with the trajectories of depression
As shown in Table 5, univariate OLR revealed that the trajectories of depression were
independently related with the variables: employment status, presence of hepatocellular
carcinoma, number of comorbidities, MELD score, the LDSI score, personal control,
emotional coping, and task-oriented coping. Investigating the effects of these variables
simultaneously on trajectory membership, with multiple OLR analyses, showed that
employment status, the presence of hepatocellular carcinoma, the number of comor-
bidities, and the MELD score do not seem to help classify subjects, when LDSI, personal
control, emotional coping, and task-oriented coping are already provided (Table 6). The
results of the OLR analysis showed that a unit increase in the LDSI score (OR = 1.23, CI
1.15–1.32) and a unit increase in the emotional coping score (OR = 1.13, CI 1.07–1.18)
were relatedwith an increase in the odds of membership in trajectories with higher levels
Table 4. Unstandardized estimates, odds ratios, and 95% confidence intervals of characteristics related
with the distinct trajectories of anxiety




Low educational level 0.14 .73 1.15 0.51 2.64
Middle educational level 0.68 .09 0.51 0.23 1.11
High educational level Reference
LDSI score 0.14 <.01 1.16 1.09 1.23
Personal control 0.11 <.01 0.89 0.84 0.95
Emotional coping style 0.12 <.01 1.13 1.07 1.19
Task-oriented coping style 0.12 <.01 0.89 0.82 0.96
Number of life events 0.19 .11 1.21 0.96 1.53
Notes. LDSI = Liver Disease Symptom Index.
pseudo-R2 = 0.40 (Cox & Snell), 0.47 (Nagelkerke); Model v2 (423) = 403.27, p = .75.
Bold values are significant.
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of depression, whereas a unit increase in the personal control score (OR = 0.84, CI 0.78–
0.90) and a unit increase in the task-oriented coping score (OR = 0.91, CI 0.85–0.98)were
related with a decrease in the odds of membership in the trajectories with higher levels of
depressive symptoms.
Discussion
This study showed that distinct trajectories of anxiety and depression are present in liver
transplant candidates. Regarding symptoms of anxiety, three distinct trajectories were
identified as follows: 1) below clinical level, 2) slightly above clinical level, and 3) high
above clinical level, comprising, respectively, 51%, 34%, and 15% of the respondents.
With respect to depressive symptoms, four distinct trajectorieswere identified as follows:
(1) belowclinical level, (2) slightly belowclinical level, (3) slightly above clinical level, and
(4) high above clinical level, comprising, respectively, 23%, 34%, 28%, and 6% of the
respondents. All trajectories were stable over time. Time accounted for 8–20% of the
variance in scoreswithin the trajectories of anxiety and for 3–20% in the variance of scores








T0 T1 T2 T3 T4 T5 T6 T7
Group percents 22.7 43.9 27.7 5.7
Figure 3. Distinct trajectories of symptoms of depression of liver transplant candidates during the
waiting-list period. Note. The bold black line represents the cut-off value (≥16) of the clinical level of
symptoms of depression. T0 = baseline measurement, T1 = 6 months after T0, T2 = 12 months after
T0, T3 = 18 months after T0, T4 = 24 months after, T5 = 30 months after T0, T6 = 36 months after
T0, T7 = 42 months after T0. [Colour figure can be viewed at wileyonlinelibrary.com]
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indicate that the baselinemeasurement is indicative of the level of depression and anxiety
of liver transplant candidates during the waiting-list period.
These results confirmed two of our hypotheses, namely that the majority of transplant
candidates would show low symptom levels of anxiety and depression and that a small
subset would show high symptom levels. These findings are in line with studies analysing
trajectories in other patient groups (Henselmans et al., 2010; Lam et al., 2013; Ng et al.,
2015; Yohannes et al., 2016). However, in contrast to other studies, our third hypothesis,
that a subset of the transplant candidates would show an increase in symptom level, was





















n = 10 p-Value
n (%)
Gender: Male 21 (58.3) 71 (68.3) 45 (68.2) 7 (70.0) .40
Marital status: Partner 28 (77.8) 81 (77.9) 52 (78.8) 7 (70.0) .91
Educational level
Low 9 (25.0) 17 (16.3) 16 (24.2) 5 (50.0) .45
Moderate 16 (44.4) 52 (50.0) 24 (36.4) 4 (40.0) .25
High 11 (30.6) 35 (33.7) 26 (39.4) 1 (10.0) Ref.
Employment status: Paid job 16 (44.4) 35 (33.7) 13 (19.7) 0 (0) .001
Primary disease
Biliary cirrhosis 15 (41.7) 37 (35.6) 24 (36.4) 2 (20.0) .53
Alcoholic cirrhosis 9 (25.0) 23 (22.1) 16 (24.2) 3 (30.0) .82
Metabolic disorder 5 (13.9) 10 (9.6) 5 (7.6) 4 (40.0) .92
Viral hepatitis 3 (8.3) 14 (13.5) 10 (15.7) 1 (10.0) .49
Cirrhosis of unknown origin 1 (2.8) 10 (9.6) 7 (10.6) 0 (0) .52
Miscellaneous 3 (8.3) 10 (9.6) 4 (6.1) 0 (0) .38
Hepato Cellular Carcinoma 9 (25.0) 20 (19.2) 4 (6.1) 1 (10.0) .01
Mean (SD)
Age (in years) 50.6 (11.2) 52.2 (12.0) 50.9 (11.1) 54.2 (5.7) .89
Number of comorbidities 1.4 (1.1) 1.9 (1.6) 1.9 (1.7) 3.6 (1.6) .01
Time since diagnosis (in years) 6.0 (6.0) 6.2 (6.7) 5.3 (5.7) 4.1 (6.5) .32
Time on waiting list
(in months)
9.4 (16.2) 5.7 (11.7) 9.5 (16.1) 8.4 (7.3) .53
MELD score 11.1 (4.9) 13.5 (5.6) 14.3 (4.9) 13.7 (5.4) .01
LDSI score 4.8 (3.9) 8.5 (4.2) 13.0 (5.3) 13.1 (4.0) <.01
Personal control 28.1 (4.2) 25.1 (4.5) 20.9 (4.6) 15.5 (4.7) <.01
Coping style
Emotional coping 16.3 (4.8) 17.5 (5.5) 22.3 (6.4) 27.4 (7.2) <.01
Task-oriented coping 26.8 (3.9) 25.4 (4.2) 24.3 (4.3) 21.9 (4.6) <.01
Avoidance coping 17.5 (5.6) 17.0 (5.1) 17.1 (4.6) 15.7 (5.0) .55
Number of life events 1.3 (1.1) 1.5 (1.2) 1.8 (1.4) 1.5 (1.4) .09
Note. MELD = Model for End-stage Liver Disease; LDSI = Liver Disease Symptom Index; ref.
= reference category.
Bold values are significant.
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not confirmed. Instead, we found that a substantial part of the transplant candidates
showed stable symptom levels slightly above the clinically relevant level of anxiety and
depression. Thismight be related to the ongoing feelings of uncertainty during thewaiting
period for a donor organ.
Of all the demographic, clinical, and individual characteristics examined, four
variables were found to be independently relatedwith both the trajectories of anxiety and
depression: the LDSI score, personal control, and emotional and task-oriented coping. In
contrast to studies that have analysed associations at a group level (Corruble et al., 2011;
Lopez-Navas et al., 2011; Sainz-Barriga et al., 2005; Santos et al., 2010), we found no
relations between demographic characteristics, such as age, sex, marital status, and
employment status and the trajectories of either anxiety or depression. However, these
finding are in line with other studies examining variables related with trajectories of
anxiety and depression in other patient groups, in which also clinical and individual
variables, such as physical symptoms and coping strategies,were found tobe predictive of
trajectories of psychological distress and no relations were found with demographic
variables (Bonanno, Kennedy, Galatzer-Levy, Lude, & Elfstr€om, 2012; Henselmans et al.,
2010; Lam et al., 2013; Van den Broek et al., 2014).
Regarding clinical characteristics, only the LDSI score, the severity of liver disease
symptoms as perceived by the transplant candidate, was found to be related with the
trajectories of anxiety and depression. Respondents who perceived the liver disease
symptoms as more severe had a higher probability of being in the trajectories with higher
levels of anxiety and depression. This finding emphasizes that adequate management of
liver disease symptoms is necessary. However, the LDSI is a subjective measurement of
disease severity, and this finding was not supported by an objective measurement of
disease severity, such as the MELD score. This may imply that altering the cognitive
appraisal of disease symptoms by giving adequate procedural and sensory information
about liver disease symptoms and possible self-management strategies may help
transplant candidates to cope with their deteriorating health. However, it is acknowl-
edged that some liver disease symptoms (e.g., itch and fatigue) are hard to treat. Therefore,
this aspect needs to be examined in future research.
Table 6. Unstandardized estimates, odds ratios, and 95% confidence intervals of characteristics related
with the distinct trajectories of depression




Employment (if yes) 0.31 .36 0.73 0.38 1.42
Hepatocellular carcinoma (if yes) 0.24 .58 0.79 0.35 1.80
Number of comorbidities 0.02 .87 1.02 0.84 1.22
MELD score 0.03 .34 1.02 0.97 1.08
LDSI score 0.22 .00 1.23 1.15 1.32
Personal control 0.18 .00 0.84 0.78 0.90
Emotional coping style 0.12 .00 1.13 1.07 1.18
Task-oriented coping style 0.09 .01 0.91 0.85 0.98
Notes. MELD = Model for End-stage Liver Disease; LDSI = Liver Disease Symptom Index.
pseudo- R2 = 0.53 (Cox & Snell), 0.58 (Nagelkerke); Model v2 (639) = 424.44, p = 1.000.
Bold values are significant.
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The individual characteristics of personal control and coping seem to play amajor role
in the development and maintenance of symptoms of anxiety and depression. Transplant
candidates with a lower level of personal control, who feel that they have no control over
the things that happen to them, and thosewhomakemore use of emotional coping, were
more likely to be in the trajectories with high symptom levels of both anxiety and
depression. Transplant candidates with a high level of personal control and who make
more use of task-oriented coping, on the other hand, seem to be less anxious and
depressed. Therefore, interventions aimed at empowering transplant candidates by
strengthening coping skills or sense of control may help to reduce symptoms of anxiety
and depression during the waiting-list period. However, evidence regarding effective
psychosocial interventions in transplant candidates is lacking (Cupples et al., 2006;
Engle, 2001). So far, only a few studies, reporting (preliminary) findings regarding
psychosocial interventions in transplant candidates and recipients, showed that this may
be effective in reducing distress (Dew et al., 2004; Hsiao et al., 2016; Napolitano et al.,
2002; Reilly-Spong, Reibel, Pearson, Koppa, & Gross, 2015). In future studies, the
effectiveness of psychosocial interventions to address psychological problems in
transplant candidates needs to be examined.
The clinical implication of our study is that identifying transplant candidates at risk of
psychological distress is warranted early in the transplant process by the use of routine
screening of psychological problems as well as variables of influence on the psychological
functioning of transplant candidates. Although the importance of screening for psycholog-
ical problems has been widely recognized (Olbrisch, Benedict, Ashe, & Levenson, 2002),
common practicemay vary between transplant centres, and psychosocial screening is a less
standardized procedure (Maldonado et al., 2012). In the literature, several instruments to
perform a structuredpsychosocial assessment of transplant candidates have been described,
of which the ‘Stanford Integrated Psychosocial Assessment for Transplantation’ (SIPAT)
(Maldonado et al., 2012) seems the most promising. The SIPAT assesses psychological
functioning as well as risk factors, such as coping style and individual traits, of influence on
adverse outcomes after transplantation. Based on the psychosocial screening, interventions
tailored to the patient’s needs, such as supportive counselling, mindfulness based stress
reduction, or coping skills training, can be undertaken to enhance the psychological well-
being of transplant candidates. In addition to psychosocial interventions aimed at reducing
distress, referral for psychological or psychiatric counselling may contribute to better
psychological well-being during the waiting-list period, which ultimately may in turn
contribute to better outcomes after transplantation.
The strength of our study was its prospective, longitudinal, and multicentre design
which made it possible to study the evolution of psychological problems over time. The
overall sample size (n = 216) was reasonable, and the response rate of 69% was
satisfactory. Furthermore, a full range of related variables (demographic, clinical, and
individual) was examined. However, the sample size was relatively small for trajectory
analysis. In addition, the use of a dynamic cohort led, resulting in non-random subject
dropout, could have influenced the results of our study. The generalizability of our results
may, therefore, be limited, and replication of our findings in larger sample sizes is
warranted.
In conclusion, distinct trajectories of symptoms of anxiety and depression were
present in liver transplant candidates. The trajectories with symptom levels above clinical
relevant levels for anxiety or depression comprised, respectively, 49% and 34% of the
respondents. The stability of these trajectories over time seems to indicate that the
baseline measurement is indicative of the course of symptoms of anxiety and depression
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during thewaiting-list period. Experiencing more liver disease symptoms, a lower level of
personal control, making more use of emotional coping, and making less use of task-
oriented coping increased the odds of membership in trajectories with higher symptom
levels for both the trajectories of anxiety and of depression. Therefore, screening of
psychological problems and related risk factors early in the transplant process – if not
already established – is recommended. Subsequently, appropriate interventions aimed at
reducing distress should be undertaken to optimize the psychological well-being of the
transplant candidate. However, evidence regarding the effectiveness of psychosocial
interventions in organ transplant candidates is lacking and needs to be studied in future
research.
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